Quest Diagnostics Stock Price, News & Analysis (NYSE:DGX)

$104.53 +1.44 (+1.40 %)
(As of 02/19/2018 04:00 PM ET)
Previous Close$104.53
Today's Range$102.35 - $104.79
52-Week Range$90.10 - $112.96
Volume771,191 shs
Average Volume1.06 million shs
Market Capitalization$14.25 billion
P/E Ratio19.01
Dividend Yield1.75%
Beta0.67

About Quest Diagnostics (NYSE:DGX)

Quest Diagnostics logoQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Receive DGX News and Ratings via Email

Sign-up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:DGX
CUSIP74834L10
Phone973-520-2700

Debt

Debt-to-Equity Ratio0.76%
Current Ratio1.24%
Quick Ratio1.15%

Price-To-Earnings

Trailing P/E Ratio19.0054545454545
Forward P/E Ratio15.86
P/E Growth1.88

Sales & Book Value

Annual Sales$7.71 billion
Price / Sales1.85
Cash Flow$7.39 per share
Price / Cash14.15
Book Value$36.35 per share
Price / Book2.88

Profitability

Trailing EPS$5.50
Net Income$772 million
Net Margins10.00%
Return on Equity15.41%
Return on Assets7.17%

Miscellaneous

Employees43,000
Outstanding Shares136,300,000

Quest Diagnostics (NYSE:DGX) Frequently Asked Questions

What is Quest Diagnostics' stock symbol?

Quest Diagnostics trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX."

How often does Quest Diagnostics pay dividends? What is the dividend yield for Quest Diagnostics?

Quest Diagnostics announced a quarterly dividend on Thursday, February 1st. Shareholders of record on Wednesday, April 4th will be given a dividend of $0.50 per share on Wednesday, April 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date of this dividend is Tuesday, April 3rd. This is an increase from Quest Diagnostics's previous quarterly dividend of $0.45. View Quest Diagnostics' Dividend History.

How will Quest Diagnostics' stock buyback program work?

Quest Diagnostics declared that its board has approved a share buyback plan on Sunday, April 9th 2017, which authorizes the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 7.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

How were Quest Diagnostics' earnings last quarter?

Quest Diagnostics Inc (NYSE:DGX) issued its quarterly earnings data on Thursday, February, 1st. The medical research company reported $1.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.37 by $0.03. The medical research company had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.93 billion. Quest Diagnostics had a return on equity of 15.41% and a net margin of 10.00%. Quest Diagnostics's revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.31 EPS. View Quest Diagnostics' Earnings History.

When will Quest Diagnostics make its next earnings announcement?

Quest Diagnostics is scheduled to release their next quarterly earnings announcement on Wednesday, April, 18th 2018. View Earnings Estimates for Quest Diagnostics.

What guidance has Quest Diagnostics issued on next quarter's earnings?

Quest Diagnostics issued an update on its FY18 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of $6.50-6.70 for the period, compared to the Thomson Reuters consensus estimate of $6.16.

Where is Quest Diagnostics' stock going? Where will Quest Diagnostics' stock price be in 2018?

19 Wall Street analysts have issued twelve-month target prices for Quest Diagnostics' shares. Their predictions range from $86.00 to $118.00. On average, they anticipate Quest Diagnostics' stock price to reach $106.11 in the next year. View Analyst Ratings for Quest Diagnostics.

Who are some of Quest Diagnostics' key competitors?

Who are Quest Diagnostics' key executives?

Quest Diagnostics' management team includes the folowing people:

  • Stephen H. Rusckowski, Chairman of the Board, President, Chief Executive Officer (Age 59)
  • Mark J. Guinan, Chief Financial Officer, Executive Vice President (Age 55)
  • James E. Davis, Executive Vice President, General Diagnostics (Age 54)
  • Michael E. Prevoznik, Senior Vice President, General Counsel (Age 55)
  • Jon Roger Cohen M.D., Senior Vice President, Group Executive - Diagnostic Solutions (Age 62)
  • Everett V. Cunningham, Senior Vice President - Commercial (Age 50)
  • Catherine T. Doherty, Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing (Age 54)
  • Carrie Eglinton Manner, Senior Vice President - Advanced Diagnostics (Age 42)
  • Daniel C. Stanzione Ph.D., Lead Independent Director (Age 71)
  • Jenne K. Britell Ph.D., Independent Director (Age 74)

Who owns Quest Diagnostics stock?

Quest Diagnostics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.65%), Macquarie Group Ltd. (5.03%), Victory Capital Management Inc. (1.82%), APG Asset Management N.V. (1.59%), Allianz Asset Management GmbH (1.58%) and Bessemer Group Inc. (1.55%). Company insiders that own Quest Diagnostics stock include Catherine T Doherty, Daniel Stanzione, Everett Cunningham, J E Davis, Jeffrey M Leiden, Jenne K Britell, John B Ziegler, Michael E Prevoznik and Stephen H Rusckowski. View Institutional Ownership Trends for Quest Diagnostics.

Who sold Quest Diagnostics stock? Who is selling Quest Diagnostics stock?

Quest Diagnostics' stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., BlackRock Inc., LSV Asset Management, UBS Asset Management Americas Inc., Shell Asset Management Co., First Quadrant L P CA, Deutsche Bank AG and KBC Group NV. Company insiders that have sold Quest Diagnostics company stock in the last year include Catherine T Doherty, Daniel Stanzione, J E Davis, Jeffrey M Leiden, Jenne K Britell, Michael E Prevoznik and Stephen H Rusckowski. View Insider Buying and Selling for Quest Diagnostics.

Who bought Quest Diagnostics stock? Who is buying Quest Diagnostics stock?

Quest Diagnostics' stock was acquired by a variety of institutional investors in the last quarter, including Rockefeller Financial Services Inc., Bessemer Group Inc., Victory Capital Management Inc., Element Capital Management LLC, American Century Companies Inc., Alliancebernstein L.P., Sit Investment Associates Inc. and Geode Capital Management LLC. View Insider Buying and Selling for Quest Diagnostics.

How do I buy Quest Diagnostics stock?

Shares of Quest Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quest Diagnostics' stock price today?

One share of Quest Diagnostics stock can currently be purchased for approximately $104.53.

How big of a company is Quest Diagnostics?

Quest Diagnostics has a market capitalization of $14.25 billion and generates $7.71 billion in revenue each year. The medical research company earns $772 million in net income (profit) each year or $5.50 on an earnings per share basis. Quest Diagnostics employs 43,000 workers across the globe.

How can I contact Quest Diagnostics?

Quest Diagnostics' mailing address is 500 PLAZA DRIVE, SECAUCUS NJ, 07940. The medical research company can be reached via phone at 973-520-2700 or via email at [email protected]


MarketBeat Community Rating for Quest Diagnostics (DGX)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  293 (Vote Outperform)
Underperform Votes:  568 (Vote Underperform)
Total Votes:  861
MarketBeat's community ratings are surveys of what our community members think about Quest Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Quest Diagnostics (NYSE:DGX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.322.262.262.47
Ratings Breakdown: 1 Sell Rating(s)
11 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $106.11$104.72$104.42$107.97
Price Target Upside: 7.11% upside3.00% upside10.14% upside2.23% upside

Quest Diagnostics (NYSE:DGX) Consensus Price Target History

Price Target History for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE:DGX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/13/2018Credit Suisse GroupUpgradeNeutral -> Outperform$107.00MediumView Rating Details
2/1/2018Piper Jaffray CompaniesReiterated RatingHold$110.00LowView Rating Details
1/29/2018Goldman Sachs GroupInitiated CoverageBuy -> Buy$117.00MediumView Rating Details
1/24/2018MizuhoSet Price TargetBuy$113.00LowView Rating Details
1/16/2018Canaccord GenuityReiterated RatingBuy$110.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageIn -> In-Line$103.00LowView Rating Details
11/25/2017Jefferies GroupSet Price TargetHold$98.00LowView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/20/2017Wells Fargo & CoLower Price TargetMarket Perform$88.00 -> $86.00N/AView Rating Details
10/20/2017CitigroupLower Price TargetNeutral$110.00 -> $98.00N/AView Rating Details
10/17/2017Craig HallumReiterated RatingHold$110.00 -> $100.00N/AView Rating Details
10/15/2017SunTrust BanksSet Price TargetHold$105.00N/AView Rating Details
9/25/2017Raymond James FinancialReiterated RatingOutperform -> Market PerformHighView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$87.00 -> $92.00LowView Rating Details
7/25/2017Bank of AmericaUpgradeNeutral -> Buy$111.00 -> $118.00MediumView Rating Details
7/19/2017BarclaysReiterated RatingHold$110.00LowView Rating Details
5/12/2017ArgusInitiated CoverageHold -> Hold$102.00LowView Rating Details
4/23/2017Deutsche BankReiterated RatingBuy$108.00 -> $115.00LowView Rating Details
4/12/2017FBR & CoBoost Price TargetOutperform$103.00 -> $110.00LowView Rating Details
6/24/2016Jyske BankDowngradeNeutral -> SellN/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
4/22/2016Royal Bank of CanadaBoost Price TargetSector Perform$70.00 -> $76.00N/AView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Quest Diagnostics (NYSE:DGX) Earnings History and Estimates Chart

Earnings by Quarter for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE DGX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/18/2018$1.47N/AView Earnings Details
2/1/2018Q4 2017$1.37$1.40$1.93 billion$1.94 billionViewN/AView Earnings Details
10/19/2017Q3 2017$1.35$1.39$1.92 billion$1.93 billionViewN/AView Earnings Details
7/25/2017Q2 2017$1.42$1.55$1.94 billion$1.94 billionViewN/AView Earnings Details
4/20/2017Q1 2017$1.18$1.33$1.87 billion$1.90 billionViewN/AView Earnings Details
1/26/2017Q416$1.27$1.31$1.86 billion$1.86 billionViewListenView Earnings Details
10/20/2016Q316$1.35$1.37$1.53 billion$1.89 billionViewListenView Earnings Details
7/21/2016Q216$1.32$1.34$1.91 billion$1.91 billionViewListenView Earnings Details
4/21/2016Q116$1.12$1.12$1.82 billion$1.86 billionViewListenView Earnings Details
1/28/2016Q415$1.19$1.19$1.85 billion$1.85 billionViewListenView Earnings Details
10/22/2015Q315$1.26$1.28$1.89 billion$1.88 billionViewListenView Earnings Details
7/23/2015Q215$1.23$1.25$1.93 billion$1.93 billionViewListenView Earnings Details
4/23/2015Q115$1.04$1.05$1.85 billion$1.84 billionViewListenView Earnings Details
1/29/2015Q414$1.05$1.08$1.85 billion$1.90 billionViewListenView Earnings Details
10/23/2014Q314$1.08$1.10$1.87 billion$1.90 billionViewListenView Earnings Details
7/24/2014Q214$1.06$1.08$1.88 billion$1.90 billionViewN/AView Earnings Details
4/24/2014Q114$0.89$0.84$1.75 billion$1.75 billionViewListenView Earnings Details
1/30/2014Q413$0.93$0.97$1.74 billion$1.76 billionViewListenView Earnings Details
10/17/2013Q313$1.20$1.02$1.84 billion$1.79 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.10$1.06$1.84 billion$1.82 billionViewListenView Earnings Details
4/17/2013Q1 2013$1.03$0.89$1.86 billion$1.80 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.02$1.01$1.83 billion$1.77 billionViewListenView Earnings Details
10/17/2012$1.18$1.18ViewN/AView Earnings Details
7/19/2012$1.17$1.17ViewN/AView Earnings Details
4/18/2012$1.01$1.07ViewN/AView Earnings Details
1/24/2012$1.06$1.23ViewN/AView Earnings Details
10/25/2011$1.11$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$1.01$1.00ViewN/AView Earnings Details
1/25/2011$0.91$0.98ViewN/AView Earnings Details
10/20/2010Q3 2010$1.00$1.05ViewN/AView Earnings Details
7/21/2010Q2 2010$1.06$1.07ViewN/AView Earnings Details
4/21/2010Q1 2010$0.98$0.89ViewN/AView Earnings Details
1/25/2010Q4 2009$0.96$0.98ViewN/AView Earnings Details
10/20/2009Q3 2009$0.96$1.02ViewN/AView Earnings Details
7/21/2009Q2 2009$0.94$1.00ViewN/AView Earnings Details
4/21/2009Q1 2009$0.82$0.89ViewN/AView Earnings Details
1/26/2009Q4 2008$0.80$0.87ViewN/AView Earnings Details
10/21/2008Q3 2008$0.81$0.86ViewN/AView Earnings Details
7/22/2008Q2 2008$0.78$0.83ViewN/AView Earnings Details
4/21/2008Q1 2008$0.70$0.72ViewN/AView Earnings Details
2/21/2008Q4 2007$0.78$0.79ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Quest Diagnostics (NYSE:DGX) Earnings Estimates

2018 EPS Consensus Estimate: $6.17
2019 EPS Consensus Estimate: $6.51
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$1.31$1.41$1.37
Q2 20184$1.52$1.80$1.63
Q3 20184$1.53$1.73$1.61
Q4 20184$1.44$1.68$1.56
Q1 20192$1.39$1.55$1.47
Q2 20193$1.58$1.83$1.70
Q3 20193$1.59$1.76$1.67
Q4 20192$1.66$1.69$1.68
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Quest Diagnostics (NYSE:DGX) Dividend Information

Next Dividend:4/18/2018
Annual Dividend:$1.80
Dividend Yield:1.72%
Dividend Growth:11.70% (3 Year Average)
Payout Ratio:32.73% (Trailing 12 Months of Earnings)
27.31% (Based on This Year's Estimates)
26.32% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE:DGX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2018quarterly$0.500.00472500472500473%4/3/20184/4/20184/18/2018
11/29/2017quarterly$0.451.83%1/8/20181/9/20181/24/2018
8/18/2017quarterly$0.451.72%10/2/201710/3/201710/18/2017
5/16/2017quarterly$0.451.71%7/6/20177/10/20177/24/2017
2/21/2017quarterly$0.451.88%4/3/20174/5/20174/19/2017
11/11/2016quarterly$0.451/6/20171/10/20171/25/2017
8/17/2016quarterly$0.401.88%9/30/201610/4/201610/19/2016
5/18/2016quarterly$0.402.1%7/1/20167/6/20167/20/2016
1/28/2016quarterly$0.402.31%4/4/20164/6/20164/20/2016
12/4/2015quarterly$0.382.22%1/8/20161/12/20161/27/2016
8/18/2015quarterly$0.382.07%10/2/201510/6/201510/21/2015
5/15/2015quarterly$0.382.09%7/6/20157/8/20157/22/2015
1/29/2015quarterly$0.382.13%4/6/20154/8/20154/22/2015
12/4/2014quarterly$0.332.03%1/9/20151/13/20151/28/2015
8/15/2014quarterly$0.332.14%10/3/201410/7/201410/22/2014
5/21/2014quarterly$0.332.3%7/7/20147/9/20147/23/2014
1/30/2014quarterly$0.332.51%4/4/20144/8/20144/23/2014
12/6/2013quarterly$0.301.99%1/3/20141/7/20141/22/2014
8/20/2013quarterly$0.302.03%9/27/201310/1/201310/16/2013
5/21/2013quarterly$0.301.96%6/28/20137/2/20137/17/2013
2/26/2013quarterly$0.302.14%3/28/20134/2/20134/16/2013
(Data available from 1/1/2013 forward)

Insider Trades

Quest Diagnostics (NYSE DGX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.75%
Institutional Ownership Percentage: 88.67%
Insider Trades by Quarter for Quest Diagnostics (NYSE:DGX)
Institutional Ownership by Quarter for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE DGX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Stephen H RusckowskiChairmanSell106,840$107.00$11,431,880.00272,956View SEC Filing  
1/24/2018Catherine T DohertySVPSell21,294$104.00$2,214,576.0090,709View SEC Filing  
1/2/2018J. E DavisEVPSell63,880$98.68$6,303,678.40101,423View SEC Filing  
9/12/2017Stephen H RusckowskiChairmanSell59,235$108.16$6,406,857.60220,049View SEC Filing  
9/11/2017Daniel StanzioneDirectorSell40,900$108.07$4,420,063.0041,991View SEC Filing  
9/11/2017Stephen H RusckowskiCEOSell53,933$108.16$5,833,393.28220,049View SEC Filing  
9/5/2017Daniel StanzioneDirectorSell3,803$108.01$410,762.0335,359View SEC Filing  
9/5/2017Stephen H RusckowskiChairmanSell2,525$108.03$272,775.75168,413View SEC Filing  
8/4/2017Jeffrey M LeidenDirectorSell296$106.66$31,571.366,000View SEC Filing  
7/27/2017Jeffrey M LeidenDirectorSell1,304$108.73$141,783.926,296View SEC Filing  
6/19/2017Catherine T DohertySVPSell59,762$107.55$6,427,403.1078,582View SEC Filing  
4/24/2017Jenne K BritellDirectorSell6,111$104.03$635,727.33View SEC Filing  
4/20/2017Michael E PrevoznikSVPSell29,513$100.00$2,951,300.0041,335View SEC Filing  
3/16/2017Michael E PrevoznikSVPSell13,987$100.00$1,398,700.0054,309View SEC Filing  
3/3/2017Catherine T DohertySVPSell7,162$98.28$703,881.3687,809View SEC Filing  
2/27/2017Michael E PrevoznikSVPSell440$97.39$42,851.6041,734View SEC Filing  
1/30/2017Catherine T DohertySVPSell80,000$90.58$7,246,400.00119,321View SEC Filing  
8/19/2016Jenne K BritellDirectorSell4,000$84.76$339,040.00View SEC Filing  
8/10/2016Jenne K BritellDirectorSell4,000$85.20$340,800.00View SEC Filing  
8/3/2016Jeffrey M LeidenDirectorSell6,345$85.62$543,258.907,233View SEC Filing  
7/25/2016John B. ZieglerDirectorSell1,000$84.36$84,360.00View SEC Filing  
5/27/2016Catherine T DohertySVPSell47,334$77.27$3,657,498.18100,402View SEC Filing  
5/12/2016Jenne K BritellDirectorSell8,000$75.68$605,440.006,025View SEC Filing  
5/9/2016Everett CunninghamSVPSell56,312$76.26$4,294,353.1274,949View SEC Filing  
5/6/2016Everett CunninghamSVPSell50,447$76.00$3,833,972.0032,649View SEC Filing  
4/25/2016Catherine T DohertySVPSell29,550$74.45$2,199,997.50106,285View SEC Filing  
3/3/2015Michael E PrevoznikSVPSell3,261$71.16$232,052.76View SEC Filing  
2/11/2015Daniel StanzioneDirectorSell8,000$70.97$567,760.00View SEC Filing  
2/4/2015Gail R WilenskyDirectorSell8,000$72.34$578,720.00View SEC Filing  
2/3/2015John B ZieglerDirectorSell8,000$71.88$575,040.00View SEC Filing  
2/2/2015Thomas F BongiornoVPSell3,000$71.50$214,500.00View SEC Filing  
11/17/2014Jon R CohenSVPSell160,029$63.13$10,102,630.77View SEC Filing  
8/8/2014Catherine T DohertySVPSell25,000$60.12$1,503,000.00View SEC Filing  
8/4/2014Michael E PrevoznikSVPSell14,377$61.01$877,140.77View SEC Filing  
7/30/2014Jenne K BritellDirectorSell8,000$62.37$498,960.00View SEC Filing  
7/30/2014Michael E PrevoznikSVPSell16,384$62.51$1,024,163.84View SEC Filing  
7/29/2014John C Md BaldwinDirectorSell8,000$62.31$498,480.00View SEC Filing  
7/28/2014Thomas F BongiornoVPSell4,000$61.72$246,880.00View SEC Filing  
7/25/2014John B ZieglerDirectorSell8,000$61.90$495,200.00View SEC Filing  
5/22/2014John ZieglerDirectorSell2,973$57.65$171,393.4516,825View SEC Filing  
5/7/2014Gary PfeifferDirectorSell10,000$55.95$559,500.0013,927View SEC Filing  
5/5/2014Mark GuinanCFOBuy4,000$55.51$222,040.0044,222View SEC Filing  
2/27/2014Jenne BritellDirectorSell10,000$52.74$527,400.0012,227View SEC Filing  
2/19/2014Michael PrevoznikSVPSell2,860$52.26$149,463.6045,762View SEC Filing  
2/18/2014Gail WilenskyDirectorSell30,000$52.93$1,587,900.0015,927View SEC Filing  
2/6/2014Timothy MainDirectorBuy5,000$50.71$253,550.005,658View SEC Filing  
11/5/2013Thomas F BongiornoVPSell16,667$62.49$1,041,520.83View SEC Filing  
10/29/2013Thomas F BongiornoVPSell6,000$59.00$354,000.00View SEC Filing  
10/25/2013Gary M PfeifferDirectorSell2,000$58.10$116,200.00View SEC Filing  
9/17/2013Catherine DohertySVPSell43,334$62.00$2,686,708.0072,295View SEC Filing  
8/14/2013Catherine DohertySVPSell33,000$59.85$1,975,050.0072,290View SEC Filing  
8/12/2013John ZieglerDirectorSell1,953$59.45$116,105.8515,876View SEC Filing  
8/8/2013Thomas BongiornoVPSell10,864$59.33$644,561.1214,086View SEC Filing  
7/23/2013Jenne K BritellDirectorSell4,200$58.99$247,758.00View SEC Filing  
6/18/2013Michael E PrevoznikSVPSell126,667$62.64$7,934,420.88View SEC Filing  
5/22/2013John B ZieglerDirectorSell31,362$62.00$1,944,444.00View SEC Filing  
5/14/2013John C Md BaldwinDirectorSell1,214$59.41$72,123.74View SEC Filing  
4/11/2013John B ZieglerDirectorSell1,470$58.35$85,774.50View SEC Filing  
1/17/2013Gary M PfeifferDirectorSell10,000$60.00$600,000.00View SEC Filing  
10/3/2012Robert HagemannCFOSell46,667$64.00$2,986,688.00View SEC Filing  
8/7/2012Stephen H RusckowskiCEOBuy5,000$59.34$296,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Quest Diagnostics (NYSE DGX) News Headlines

Source:
DateHeadline
Quest Diagnostics (DGX) Upgraded to "Outperform" by Credit Suisse GroupQuest Diagnostics (DGX) Upgraded to "Outperform" by Credit Suisse Group
www.americanbankingnews.com - February 18 at 8:10 PM
DGX Makes Bullish Cross Above Critical Moving AverageDGX Makes Bullish Cross Above Critical Moving Average
www.nasdaq.com - February 15 at 5:32 PM
Benzingas Top Upgrades, Downgrades For February 13, 2018 - BenzingaBenzinga's Top Upgrades, Downgrades For February 13, 2018 - Benzinga
www.benzinga.com - February 13 at 3:32 PM
Top NasdaqGS Healthcare Dividend Paying CompaniesTop NasdaqGS Healthcare Dividend Paying Companies
finance.yahoo.com - February 9 at 7:51 AM
Quest Diagnostics Banks on Alliances, Long-Term View SolidQuest Diagnostics Banks on Alliances, Long-Term View Solid
finance.yahoo.com - February 8 at 3:31 PM
William Blair Research Analysts Lift Earnings Estimates for Quest Diagnostics Inc (DGX)William Blair Research Analysts Lift Earnings Estimates for Quest Diagnostics Inc (DGX)
www.americanbankingnews.com - February 8 at 9:48 AM
Quest Diagnostics Inc to Post Q2 2019 Earnings of $1.83 Per Share, William Blair Forecasts (DGX)Quest Diagnostics Inc to Post Q2 2019 Earnings of $1.83 Per Share, William Blair Forecasts (DGX)
www.americanbankingnews.com - February 7 at 1:44 PM
Technical Perspectives on Medical Research Stocks -- OpGen, PRA Health Sciences, Quest Diagnostics, and TrovaGeneTechnical Perspectives on Medical Research Stocks -- OpGen, PRA Health Sciences, Quest Diagnostics, and TrovaGene
www.prnewswire.com - February 7 at 6:34 AM
Quest Diagnostics (DGX) Upgraded by Zacks Investment Research to "Buy"Quest Diagnostics (DGX) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - February 6 at 9:58 PM
Quest Diagnostics Inc (DGX) Expected to Post Quarterly Sales of $1.96 BillionQuest Diagnostics Inc (DGX) Expected to Post Quarterly Sales of $1.96 Billion
www.americanbankingnews.com - February 6 at 5:34 AM
Quest Diagnostics Inc (DGX) to Post FY2022 Earnings of $8.40 Per Share, Gabelli ForecastsQuest Diagnostics Inc (DGX) to Post FY2022 Earnings of $8.40 Per Share, Gabelli Forecasts
www.americanbankingnews.com - February 5 at 9:32 AM
KeyCorp Equities Analysts Lift Earnings Estimates for Quest Diagnostics Inc (DGX)KeyCorp Equities Analysts Lift Earnings Estimates for Quest Diagnostics Inc (DGX)
www.americanbankingnews.com - February 5 at 3:34 AM
William Blair Comments on Quest Diagnostics Incs Q1 2018 Earnings (DGX)William Blair Comments on Quest Diagnostics Inc's Q1 2018 Earnings (DGX)
www.americanbankingnews.com - February 5 at 2:30 AM
Quest Diagnostics Inc (DGX) Expected to Announce Earnings of $1.42 Per ShareQuest Diagnostics Inc (DGX) Expected to Announce Earnings of $1.42 Per Share
www.americanbankingnews.com - February 4 at 11:38 AM
Here's why Alibaba is selling off despite great earningsHere's why Alibaba is selling off despite great earnings
finance.yahoo.com - February 3 at 3:34 PM
UPS shares sink as costs projected to riseUPS shares sink as costs projected to rise
finance.yahoo.com - February 3 at 3:34 PM
Time Warner and AT&T report solid earnings as that antitrust trial loomsTime Warner and AT&T report solid earnings as that antitrust trial looms
finance.yahoo.com - February 3 at 3:34 PM
Facebook and Microsoft are reversing early weakness after earningsFacebook and Microsoft are reversing early weakness after earnings
finance.yahoo.com - February 3 at 3:34 PM
Contrasting American Renal Associates (ARA) and Quest Diagnostics (DGX)Contrasting American Renal Associates (ARA) and Quest Diagnostics (DGX)
www.americanbankingnews.com - February 3 at 11:04 AM
Quest Diagnostics (DGX) Research Coverage Started at Credit Suisse GroupQuest Diagnostics (DGX) Research Coverage Started at Credit Suisse Group
www.americanbankingnews.com - February 3 at 12:04 AM
Quest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $11. ... - Yahoo NewsQuest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $11. ... - Yahoo News
finance.yahoo.com - February 2 at 3:34 PM
Quest Diagnostics (DGX) Tops Q4 Earnings, Revenues Estimates - NasdaqQuest Diagnostics (DGX) Tops Q4 Earnings, Revenues Estimates - Nasdaq
www.nasdaq.com - February 2 at 3:34 PM
Quest Diagnostics (DGX) Tops Q4 Earnings, 2018 View Strong - NasdaqQuest Diagnostics (DGX) Tops Q4 Earnings, 2018 View Strong - Nasdaq
www.nasdaq.com - February 2 at 3:34 PM
William Blair Comments on Quest Diagnostics Incs Q1 2019 Earnings (DGX)William Blair Comments on Quest Diagnostics Inc's Q1 2019 Earnings (DGX)
www.americanbankingnews.com - February 2 at 3:12 PM
Quest Diagnostics Completes Acquisition of MedXMQuest Diagnostics Completes Acquisition of MedXM
finance.yahoo.com - February 2 at 7:35 AM
Quest Diagnostics (DGX) Tops Q4 Earnings, 2018 View StrongQuest Diagnostics (DGX) Tops Q4 Earnings, 2018 View Strong
www.zacks.com - February 1 at 3:31 PM
Quest Diagnostics beats Street 4Q forecastsQuest Diagnostics beats Street 4Q forecasts
finance.yahoo.com - February 1 at 3:31 PM
Quest Diagnostics (DGX) Tops Q4 Earnings, Revenues EstimatesQuest Diagnostics (DGX) Tops Q4 Earnings, Revenues Estimates
finance.yahoo.com - February 1 at 3:31 PM
Quest Diagnostics (DGX) Issues Quarterly  Earnings Results, Beats Expectations By $0.03 EPSQuest Diagnostics (DGX) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - February 1 at 9:52 AM
Quest Diagnostics (DGX) Releases FY18 Earnings GuidanceQuest Diagnostics (DGX) Releases FY18 Earnings Guidance
www.americanbankingnews.com - February 1 at 8:56 AM
Quest Diagnostics Inc (DGX) Raises Dividend to $0.50 Per ShareQuest Diagnostics Inc (DGX) Raises Dividend to $0.50 Per Share
www.americanbankingnews.com - February 1 at 8:34 AM
Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per QuarterQuest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
finance.yahoo.com - February 1 at 7:49 AM
Quest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $11. ...Quest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $11. ...
finance.yahoo.com - February 1 at 7:49 AM
Quest Diagnostics Incorporated to Host Earnings CallQuest Diagnostics Incorporated to Host Earnings Call
finance.yahoo.com - February 1 at 7:49 AM
Is Quest Diagnostics Incorporated (NYSE:DGX) A Good Pick For Income Investors?Is Quest Diagnostics Incorporated (NYSE:DGX) A Good Pick For Income Investors?
finance.yahoo.com - February 1 at 7:49 AM
Quest Diagnostics Inc (DGX) Chairman Sells $11,431,880.00 in StockQuest Diagnostics Inc (DGX) Chairman Sells $11,431,880.00 in Stock
www.americanbankingnews.com - January 31 at 6:24 PM
Goldman Sachs Views Lab Stocks as Attractive, Neutral on Diagnostics; LabCorp (LH) Top Pick, Myriad (MYGN) the ... - StreetInsider.comGoldman Sachs Views Lab Stocks as Attractive, Neutral on Diagnostics; LabCorp (LH) Top Pick, Myriad (MYGN) the ... - StreetInsider.com
www.streetinsider.com - January 31 at 7:49 AM
ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
finance.yahoo.com - January 30 at 3:32 PM
Quest Diagnostics Inc (DGX) Receives Consensus Rating of "Hold" from AnalystsQuest Diagnostics Inc (DGX) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - January 30 at 1:32 PM
Goldman Sachs Group Begins Coverage on Quest Diagnostics (DGX)Goldman Sachs Group Begins Coverage on Quest Diagnostics (DGX)
www.americanbankingnews.com - January 29 at 6:02 PM
Insider Selling: Quest Diagnostics Inc (DGX) SVP Sells 21,294 Shares of StockInsider Selling: Quest Diagnostics Inc (DGX) SVP Sells 21,294 Shares of Stock
www.americanbankingnews.com - January 26 at 9:14 PM
Quest Diagnostics to Buy MedXM, Boost Home Health ServicesQuest Diagnostics to Buy MedXM, Boost Home Health Services
finance.yahoo.com - January 26 at 3:32 PM
Gabelli Equities Analysts Increase Earnings Estimates for Quest Diagnostics Inc (DGX)Gabelli Equities Analysts Increase Earnings Estimates for Quest Diagnostics Inc (DGX)
www.americanbankingnews.com - January 26 at 11:38 AM
Contrasting Quest Diagnostics (DGX) & Community Health Systems (CYH)Contrasting Quest Diagnostics (DGX) & Community Health Systems (CYH)
www.americanbankingnews.com - January 25 at 9:02 PM
Quest Diagnostics Inc (DGX) Forecasted to Post FY2018 Earnings of $6.76 Per ShareQuest Diagnostics Inc (DGX) Forecasted to Post FY2018 Earnings of $6.76 Per Share
www.americanbankingnews.com - January 25 at 12:44 PM
Quest Diagnostics (DGX) Set to Announce Earnings on ThursdayQuest Diagnostics (DGX) Set to Announce Earnings on Thursday
www.americanbankingnews.com - January 25 at 2:02 AM
Quest Diagnostics (DGX) Given a $113.00 Price Target at MizuhoQuest Diagnostics (DGX) Given a $113.00 Price Target at Mizuho
www.americanbankingnews.com - January 24 at 11:52 PM
What to Expect From Quest Diagnostics (DGX) in Q4 Earnings - NasdaqWhat to Expect From Quest Diagnostics (DGX) in Q4 Earnings - Nasdaq
www.nasdaq.com - January 24 at 6:21 AM
Quest Diagnostics to acquire MedXMQuest Diagnostics to acquire MedXM
seekingalpha.com - January 23 at 6:28 PM
What to Expect From Quest Diagnostics (DGX) in Q4 EarningsWhat to Expect From Quest Diagnostics (DGX) in Q4 Earnings
finance.yahoo.com - January 23 at 2:41 PM

SEC Filings

Quest Diagnostics (NYSE:DGX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Quest Diagnostics (NYSE:DGX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Quest Diagnostics (NYSE DGX) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.